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Background: Quantitative PCR is rapidly becoming the standard method for analyzing gene expression in a wide
variety of biological samples however it can suffer from significant error if stably expressed reference genes are
not identified on which to base the analysis. Suitable reference genes for qPCR experiments on Staphylococcus
pseudintermedius have yet to be identified.
Results: Three reference genes in S. pseudintermedius were identified and validated from a set of eight potential
genes (proC, gyrB, rplD, rho, rpoA, ftsZ, recA, sodA). Two strains of S. pseudintermedius were used, and primer
specificity and efficiency were confirmed and measured. Ranking of the genes with respect to expression stability
revealed gyrB, rho and recA as the best reference genes. This combination was used to quantify expression of a
single biofilm associated gene, icaA, in logarithmic, stationary and biofilm growth phases, revealing that expression
was significantly upregulated in the biofilm growth phase in both strains.
Conclusion: Three reference genes, gyrB, rho and recA, were identified and validated for use as reference genes
for quantitative PCR experiments in S. pseudintermedius. Also, the biofilm associated gene icaA was shown to be
significantly upregulated in biofilm samples, consistent with its role in biofilm production.
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Staphylococcus pseudintermedius is a common com-
mensal organism of canines, but is also one of the most
common causes of opportunistic infections [1-3]. Re-
cently, methicillin resistant S. pseudintermedius (MRSP)
has emerged and disseminated internationally [4,5], with
2 major sequence types (ST68 and ST71) representing
the variety of clinical infections in most regions [3]. One
area of concern is the ability of this bacterium to produce
biofilm something that might be an important virulence
factor and complicate elimination of infections [6,7]. Ex-
pression of genes pertaining to initial bacterial surface
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unless otherwise stated.formation, such as microbial surface components recog-
nizing adhesive matrix molecule (MSCRAMMs) which
mediate cellular adhesion, and the intracellular adhesion
(icaADBC) operon [8], reported to be at least partially re-
sponsible for biofilm formation, likely affect the in vivo
behavior of this organism, including resistance to therapy
[9,10]. While there is significant postulation regarding
these factors, understanding of the expression of anti-
microbial resistance and biofilm associated genes in
S. pseudintermedius and the subsequent clinical implica-
tions is still poor.
Quantitative real-time PCR (qPCR) is increasingly
employed to quantify gene expression. While it can be very
sensitive and specific, there are numerous pitfalls in its ap-
plication that can easily result in misleading and incorrect
conclusions. On of the most frequent errors is a failure to
confirm the constitutive expression of the reference genesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 RNA quality and recovery
Sample ID Concentration
(ng/μL)
260/280 260/230 Total RNA
recovery (μg)
RIN
A42 log A 616.2 2.15 1.09 61.6 9.6
A42 log B 771.4 2.15 2.27 77.1 n.t.
A42 log C 805.5 2.15 2.27 80.5 9.0
A54 log A 823.1 2.14 2.20 82.3 9.4
A54 log B 919.4 2.13 1.67 91.9 n.t.
A54 log C 921.6 2.14 2.03 92.2 9.4
A42 stat A 535.4 2.10 2.00 53.5 9.2
A42 stat B 449.4 2.02 1.95 44.9 n.t.
A42 stat C 493.0 2.05 1.66 49.3 8.8
A54 stat A 403.3 2.05 2.05 40.3 8.5
A54 stat B 630.1 2.13 1.89 63.0 n.t
A54 stat C 397.5 2.05 1.89 39.7 8.8
A42 BF A 732.4 2.12 2.17 36.6 9.4
A42 BF B 738.6 2.11 2.18 36.9 n.t
A42 BF C 887.3 2.12 2.19 44.4 8.4
A54 BF A 606.9 2.11 1.97 30.3 9.5
A54 BF B 337.9 2.06 1.74 16.9 n.t
A54 BF C 421.9 2.03 1.99 21.1 8.9
(n.t: not tested, log: logarithmic, stat: stationary, BF: biofilm samples).
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Normalization of results in qPCR is vital to limit variability
introduced by experimental conditions, sample preparation
and analysis, and is one of the main underlying tenets of
qPCR analysis. Selection of inappropriate reference genes
can result in grossly incorrect conclusions owing to the
miscalculation of gene expression. These and other reasons
have prompted the development of minimum information
for publication of qPCR experiments (MIQE) guidelines to
ensure integrity, consistency and transparency of qPCR ex-
periments, including standards for all aspects of experi-
mental design, analysis and reporting [11].
Current recommendations suggest a minimum of
three reference genes (ideally with M values below 1
for heterogenous samples), and the inclusion of add-
itional genes as necessary to obtain a pairwise variation
value < 0.15 [12]. This requires specific validation of
candidate reference genes in the bacterium (and ideally
strains) to be studied, something that is lacking for
S. pseudintermedius. While multiple qPCR studies have
been performed in various Staphylococcus spp [13,14],
study and validation of reference genes in S. pseudinter-
medius is lacking, and it cannot be assumed that data
from other staphylococci apply to this species.
The objectives of this study were to evaluate several
potential reference genes in S. pseudintermedius, to identify
the optimum gene or gene combinations for future qPCR
expression studies and to evaluate expression of icaA using
validated reference genes.
Results and discussion
RNA isolation
The modified protocol afforded good to excellent yields
(mean yield 53.5 ± 23.4 μg, range 16.9 – 92.2 μg, concen-
tration 639 ± 94 μg/μL), as well as good RNA purity and
integrity (RNA Integrity Number mean 9.1 ± 0.4) (Table 1),
though there was evidence of some mild contamination
from purification reagents (260/230 < 2). qPCR was per-
formed on all RNA preparations to confirm DNA elimin-
ation; quantification cycle numbers were at least 20 cycles
lower for RNA samples than equivalent amounts of DNA.
The modified protocol for RNA and DNA extraction,
namely the inclusion of lysostaphin (and Dispersin B for
biofilm samples) in the initial lysis buffer resulted in sub-
stantial and reproducible increases in RNA and DNA
yield during harvesting (results not shown). Dispersin B
catalyzes the hydrolysis of polysaccharide intercellular
adhesin (PIA), a major constituent of the extracellular
matrix of Staphylococcus spp. biofilms. Incorporating
this enzyme in the solution to recover the biofilm from a
surface, and in the lysis buffer is thought to increase
recovery by enzymatically degrading the extracellular
matrix of biofilm, releasing adherent bacteria for recov-
ery, and exposing them to the lysis solution. The abilityof this simple method to yield an adequate quantity and
quality of DNA from biofilm-embedded bacteria was an
important finding and will facilitate future studies of gene
expression in biofilms.
Amplification specificity and determination of PCR
efficiency of reference genes
Quantification cycle (Cq) for each reaction was plotted
against the log of DNA concentration, and the slopes of
the curves were used to calculate the PCR efficiency values,
which ranged from 1.79 to 1.87, with excellent regression
coefficients (Table 2). Despite the range in melting points
of the qPCR products (Table 2), all primers amplified well
under the conditions listed. Melt curve analysis showed a
single melt curve for each target gene, and DNA agarose
gel electrophoresis revealed a single peak for each product.
Sequencing of the qPCR products matched the sequence
of the desired target in all cases.
Comparison of qPCR reaction products
Melt curve analyses and gel electrophoresis were also
performed on and compared between samples recovered
from qPCR reactions performed on cDNA prepared
using random hexamers, single gene specific primer
and combination gene specific primer reverse transcript re-
actions; there were no differences in any of the products
obtained from those obtained from qPCR or genomic
DNA.
Table 2 Reference and target gene efficiency determination
and amplicon melting points, r2 values are regression
coefficients for the curves
Candidate
reference genes
Slope of
the curve
r2 on the
slope
PCR
efficiency
Melting
temperature (°C)
proC −3.78 0.997 1.84 80.0
gyrB −3.85 0.998 1.82 79.5
rplD −3.86 0.998 1.82 75.5
rho −3.68 0.997 1.87 81.0
rpoA −3.89 0.996 1.81 76.5
ftsZ −3.85 0.998 1.82 79.0
recA −3.83 0.998 1.82 81.0
sodA −3.97 0.996 1.79 79.5
Target gene
icaA −3.92 0.995 1.80 80.5
Table 4 Pairwise variation in normalization factor for
combinations of reference genes
Number of genes used Pairwise variation of normalization factors
2 vs 3 0.119
3 vs 4 0.096
4 vs 5 0.082
5 vs 6 0.112
6 vs 7 0.107
7 vs 8 0.135
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Relative expression levels (quantification cycle numbers)
were entered into the Microsoft Excel (Microsoft Canada,
Mississauga, ON) visual basic application geNorm [12],
which calculated stability values (M values) for each
gene (Table 3). GeNorm was also used to calculate
normalization factors using combinations of the most
stably expressed genes, and calculated the pairwise
variation between these factors to identify the optimum
number of reference genes to use (Table 4). The three
genes with the lowest individual M values were used in
combination (rho, recA, gyrB) for subsequent expres-
sion analysis.
While stability of expression of reference genes is
important, reference genes ideally also have a high PCR
efficiency. The primers we identified had efficiency ran-
ging from 1.79 to 1.84 (with a value of 2.0 representing
100% efficiency), and while the final three genes used for
normalization did not have the highest efficiencies, the
values are accounted for during normalization of qPCR
expression data.
With respect to the identification of reference genes,
these results are specifically only applicable to the twoTable 3 GeNorm gene stability (M) values
Candidate reference genes geNorm M value
proC 0.701
gyrB 0.604
rplD 0.769
rho 0.595
rpoA 0.663
ftsZ 0.848
recA 0.599
sodA 1.150strains studied under the three growth phases sampled.
However, the two strains that were studied comprised the
two main international MRSP clones [3], suggesting that
these genes will be suitable for broad studies of MRSP gene
expression. The excellent stability of expression of these
genes over the broad range of conditions studied also indi-
cate that these targets will likely function very well as refer-
ence genes over a generally broad range of conditions.
icaA expression
Expression of icaA was significantly higher in the biofilm
compared to logarithmic and stationary phases (p = 0.0093
(A42), p < 0.0001 (A54), Figure 1). Individual Tukey’s post-
hoc p-values for individual comparisons were for logarith-
mic vs biofilm p = 0.015 (A42); p = 0.0001 (A54) and for
stationary vs biofilm p = 0.015 (A42); p = 0.0002 (A54).
There was no difference in expression level between loga-
rithmic and stationary phases for either strain, individual
Tukey post-hoc p > 0.9999 (A42), p = 0.8258 (A54).
These findings are unsurprising given the role of this
gene in formation of polysaccharide intracellular adhe-
sin, but it is noteworthy that such a profound alteration
in expression was detectable. Further investigation of ex-
pression of this gene under other conditions and on a
variety of surfaces, as well as studies of expression of
other biofilm associated genes such as MSCRAMMs.Figure 1 Relative expression of icaA.
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Proper development of qPCR assays, including reference
gene assessment, is a critical quality control step in the
application of this tool. This study has identified a group of
S. pseudintermedius reference genes, and used those
reference genes to demonstrate a significant expression
change in a biofilm associated gene. This information
provides a vital background for the performance of gene
expression studies in this increasingly important veterinary
pathogen.
Methods
Bacterial strains and culture conditions
Two canine S. pseudintermedius strains were chosen,
representing the two main international MRSP clones,
sequence type (ST) 68 (strain A42) and ST71 (strain A54).
These two strains were isolated from clinical infections,
and were both previously classified as moderate biofilm
formers using a polystyrene plate assay (unpublished data).
Isolates were grown in tryptic soy broth supplemented
with 1% (w/v) dextrose for all growth conditions. Samples
were isolated as single colonies from streak plates prepared
from −80°C freezer stocks on Columbia blood agar (Sheep
blood), and incubated aerobically in a shaker at 37°C. Loga-
rithmic phase growth was defined in a preliminary study
(data not presented) as >1 and <6 hours of growth, and
OD600 > 0.5 and <2.0; stationary phase growth was col-
lected at >12 (12–24) hours, and OD600 > 2.2. For loga-
rithmic and stationary samples, 109 cells were harvested,
centrifuged (13,000 × g for 30 seconds) to pellet the
cells, then immediately processed to recover RNA as de-
scribed below. Biofilm samples were produced by incu-
bating glass Erlenmeyer flasks unshaken at 37°C for >48
(48–54) hours, at which time a visible film was present
on the flask surface. The media was removed, and the
flasks were washed twice with phosphate buffered saline
(PBS, pH 7.4). Biofilm was harvested by incubating the
flask with 10 ug/mL Dispersin B (Kane Biotech, Winnipeg,
MB) a biofilm degrading enzyme isolated from Aggregati-
bacter actinomycetemcomitans, in PBS, shaking the flask
for five minutes at room temperature (the visible film dis-
persed producing a turbid solution), and then pelleting by
centrifugation (13,000 × g for 30 seconds) the cells present
in the solution. The pellet of cells was immediately proc-
essed to recover RNA as described below.
Primer design and determination of PCR efficiency
Eight candidate reference genes (Table 5) were evaluated
using the validation software geNorm [12]. These genes
had been examined in S. epidermidis and S. aureus in
previous studies [13,14], and analogous sequences were
identified in S. pseudintermedius for evaluation in this
study. Primers were designed using a combination of
GeneRunner software version 3.05 (Hasting Software, Inc.)and the National Centre for Biotechnology Information
online primer designing tool (http://www.ncbi.nlm.nih.
gov/tools/primer-blast/) using gene sequences for all
strains of Staphylococcus pseudintermedius (strains ED99
and HKU10-03) available from Genbank (http://www.ncbi.
nlm.nih.gov/genbank/).
Primers for icaA were available from a previous study
[15] and were validated for use in qPCR as described for
the potential reference gene primers.
Pooled chromosomal DNA from the two strains under
investigation (mixture of equal concentrations from each
strain) was used to generate dilution series for PCR
efficiency calculations and for amplicon melting point
assessment. For efficiency determination, a six fold dilu-
tion series was prepared in triplicate. Twenty μL reac-
tions containing from 100 ng to 0.1 pg of total DNA
were prepared in 96 well plates (Bio-Rad) using the
LightCycler 480 SYBR Green I Master qPCR reaction
mixture (Roche Applied Science, Indianapolis, IN), fol-
lowing the manufacturer’s instructions. Primer concen-
tration was 0.5 μM for each primer in the final reaction.
A Bio-Rad C1000 thermal cycler with a CFX96 Real-
Time System and Bio-Rad CFX Manager 2.0 software
(Bio-Rad Life Sciences, Mississauga, ON) was used to run
the following optimized thermocycling parameters: de-
naturation at 95°C for 10 minutes followed by 50 cycles of
10 seconds at 95°C, 30 seconds at 62°C, 30 seconds at 72°C,
then a melting curve analysis running from 65 to 95°C with
steps and measurements every 0.5°C. The thermocycler
software calculated quantification cycle (Cq), efficiency and
regression coefficients from the recovered data. Amplicon
identity and primer specificity was confirmed by sequen-
cing of the PCR products (fluorescent capillary Sanger
method, Macrogen, Seoul, Korea), melt curve analysis and
gel electrophoresis. qPCR reactions were tested over a
range of primer concentrations and annealing temperatures
and times to determine optimum reaction conditions.
DNA isolation
Cells were collected from a logarithmic phase sample
as described above, and processed using the High Pure
PCR Template Preparation Kit (Roche Applied Science,
Indianapolis, IN) following the manufacturer’s instruc-
tions with the exception that lysostaphin (Sigma-Aldrich,
Oakville, ON) was added at 0.1 mg/mL in the initial lysis
step. Concentration and purity at 260/280 nm was mea-
sured using a Nanodrop ND-100 spectrophotometer
(Nanodrop Technologies Inc., Wilmington, DE), and the
samples were qualitatively examined for shearing by DNA
gel electrophoresis.
RNA isolation
Each pellet of cells was resuspended in 2 mL PBS (pH 7.4),
centrifuged to a pellet and the supernatant discarded. The
Table 5 Candidate reference and target genes, primers and amplicon sizes
Candidate reference genes Function Primer sequence (5’-3’) Expected size (bp)
proC Pyrrolidine-5-carboxylate reductase proC-F gccgaatacaaatgcgcacg 180
proC-R aaaaatgcagggccacttcc
gyrB DNA gyrase B subunit gyrB-F gcgtccgttgattgaagcg 240
gyrB-R aacgtcacttgcaacatcgc
rplD 50S ribosomal protein L4 rplD-F gcctaagaaaatgcgtcg 237
rplD-R ccttctggtgttgtgattg
rho Transcription termination factor Rho rho-F cacgtaaaagttgctgaattg 215
rho-R cctgcttcgatatttctgg
rpoA DNA-directed RNA polymerase sigma factor rpoA-F ctatcatcattaccaggtgc 231
rpoA-R caaaatttcaacatcactgtc
ftsZ Cell division protein ftsZ ftsZ-F gtccattcagtttcgaagg 254
ftsZ-R catgattgttttaacgtcagc
recA Recombinase A recA-F gcattaggtgtagatattgataac 228
recA-R ggctgcagaaagtttacgc
sodA Superoxide dismutase sodA-F cgcaaacttagacagcgtacc 227
sodA-R caacaagccaagcccaacc
Target Gene
icaA N-acetylglucosaminyl-transferase icaA-F ttgcccaccttgtgcccacc 178
icaA-R tgaggctgtagggcgttggga
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Qiagen RNeasy Mini kit (Qiagen, Germantown, MD),
following the manufacturer’s instructions, with the fol-
lowing changes. The cells were initially resuspended in
tris-EDTA buffer (pH 7.5) containing 15 mg/ml lysozyme
(Sigma-Aldrich), 2 mg/mL proteinase K (Sigma-Aldrich),
25 μg/mL Dispersin B (Kane Biotech Inc., Winnipeg,
MB) and 0.1 mg/mL lysostaphin (Sigma-Aldrich). All
optional steps for additional washes or spins during the
procedure were performed. Logarithmic and stationary
phase samples were eluted from the purification column
with two volumes of 50 μL sterile nuclease free water,
biofilm samples were eluted with one volume of 50 μL
(volumes chosen so as to obtain final RNA concentra-
tions above 400 ng/μL). All samples were treated with
the DNAfree DNAse kit (Ambion, Austin, TX) as per the
manufacturer’s instructions using a total of 2 units per
reaction, added in two aliquots. A Nanodrop ND-100
spectrophotometer (Nanodrop Technologies Inc.) was
used to measure RNA concentration and purity at 260/
280 nm. Three samples of each RNA sample were mea-
sured and the measured concentrations were averaged.
Representative samples were submitted for Bioanalyzer
analysis (Agilent Technologies, Santa Clara, CA). Real-
time PCR was performed using the efficiency determin-
ation protocol on RNA samples to confirm the absence
of DNA using gyrB primers. RNA samples were stored
at −20 to −80°C until further use.Reverse transcription/cDNA preparation
Two μg of total RNA was used in each 20 μL gene spe-
cific reverse transcription reaction using the Omniscript
RT PCR kit (Qiagen), using 10 μM of each primer,
0.5 mM dNTP, 1 U reverse transcription enzyme, pro-
vided buffer diluted to 1x and the remainder as water. A
mixture of forward and reverse primers for all nine
genes was used. Reactions were incubated at 42°C for
60 minutes. Reverse transcription products were purified
using the QIAquick PCR purification kit (Qiagen) as per
the manufacturer’s instructions, eluted with 100 μL Qiagen
EB buffer, and stored at −20°C until further use.
qPCR for gene stability and icaA
The same protocol for efficiency testing was used to
examine stability of potential reference gene and icaA
expression, with the only change being that only 30 cycles
were performed. In triplicate, cDNA produced from all
three growth phases were subjected to qPCR (as described
for the efficiency evaluation) for each candidate gene.
In each 20 μL reaction, 5 μL of purified RT reaction
product (equivalent to 100 ng of RNA prior to reverse
transcription) was used. No template (negative; water)
and DNA (positive; 100 ng DNA) controls were included
in each run. No amplification was identified in negative
controls. Intra-plate normalization was performed using
the measured level of icaA in the positive control on each
plate.
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Expression of icaA was compared between the three
growth phases for the two strains using the combination
of three reference genes. Normalization factors, calibra-
tion factors and relative expression was calculated as per
Hellemans et al. [16]. A one-way ANOVA with Tukey’s
post-hoc test was perfomed to compare expression be-
tween growth phases. P-values < 0.05 were considered
significant.
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